Related references
Note: Only part of the references are listed.
Article
Public, Environmental & Occupational Health
Gilmar Reis et al.
Summary: Treatment with fluvoxamine (100 mg twice daily for 10 days) among high-risk outpatients with early diagnosed COVID-19 reduced the need for hospitalisation defined as retention in a COVID-19 emergency setting or transfer to a tertiary hospital. The trial showed a higher probability of superiority (99.8%) surpassing the prespecified threshold of 97.6%.
LANCET GLOBAL HEALTH
(2022)
Article
Medicine, General & Internal
Michael C. Sneller et al.
Summary: This study aimed to characterize medical sequelae and persistent symptoms in COVID-19 survivors. The results showed a high burden of persistent symptoms after COVID-19, but extensive diagnostic evaluation did not reveal a specific cause in most cases. Women and individuals with a history of anxiety disorder had an increased risk for post-acute sequelae of SARS-CoV-2 infection.
ANNALS OF INTERNAL MEDICINE
(2022)
Article
Immunology
Ili Margalit et al.
Summary: A study conducted in a COVID-19 recovery clinic showed that long-COVID fatigue may be related to autonomic dysfunction, impaired cognition, and decreased mood.
CLINICAL INFECTIOUS DISEASES
(2022)
Review
Pharmacology & Pharmacy
Udo Bonnet et al.
Summary: This study conducted a scoping review to investigate the effects of antidepressants on SARS-CoV-2 infection and COVID-19. The review found that fluvoxamine and fluoxetine have the best evidence for potential anti-COVID-19 effects. Preliminary evidence suggests that patients exposed to selective serotonin reuptake inhibitors (SSRI) or selective norepinephrine reuptake inhibitors (SNRI) might have a reduced mortality risk, and trazodone could reduce SARS-CoV-2 infection rates. However, some studies did not find a significant influence of antidepressants on COVID-19 morbidity and mortality, and one study reported increased mortality.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
(2022)
Article
Biochemistry & Molecular Biology
Ziyad Al-Aly et al.
Summary: This study analyzed the US Department of Veterans Affairs national healthcare databases to investigate the occurrence of Long COVID and death risk after breakthrough SARS-CoV-2 infection. The findings showed that vaccination significantly reduced the risk of death and post-acute sequelae but did not eliminate them completely. These results underscore the importance of further research on prevention and post-acute care for breakthrough infections.
Article
Medicine, General & Internal
Adam S. Lauring et al.
Summary: mRNA vaccines were highly effective in preventing covid-19 associated hospital admissions related to the alpha, delta, and omicron variants. Three vaccine doses were required for protection against omicron, while two doses provided protection against delta and alpha variants. Omicron variant showed lower disease severity compared to delta variant but still resulted in morbidity and mortality. Vaccinated patients had lower disease severity than unvaccinated patients for all the variants.
BMJ-BRITISH MEDICAL JOURNAL
(2022)
Article
Infectious Diseases
S. Morioka et al.
Summary: This study aimed to compare the prevalence of post COVID-19 condition of the Omicron variant with other strains. Patients who recovered from Omicron COVID-19 infection were interviewed, while patients infected with other strains were surveyed via a self-reporting questionnaire. After matching cases with controls, it was found that the prevalence of post COVID-19 condition was lower in the Omicron group compared to the control group.
JOURNAL OF INFECTION AND CHEMOTHERAPY
(2022)
Letter
Medicine, General & Internal
Michela Antonelli et al.
Article
Multidisciplinary Sciences
Qiao Wu et al.
Summary: People who have COVID-19 can experience symptoms for months, with some developing long COVID. A study based on a representative sample in the US found that about 23% of infected individuals experienced new-onset symptoms during infection, with the most common being headache, runny or stuffy nose, abdominal discomfort, fatigue, and diarrhea. Obesity, hair loss, headache, and sore throat were associated with increased risk of long COVID.
SCIENTIFIC REPORTS
(2022)
Article
Microbiology
Cesar Fernandez-de-las-Penas et al.
Summary: This study compared the symptoms during the acute phase of infection and post-COVID-19 symptoms between individuals hospitalized with different variants of SARS-CoV-2. The study found differences in symptoms between individuals infected with the Wuhan, Alpha, or Delta variant, with the Wuhan variant showing a greater number of symptoms at hospital admission and the Delta variant showing differences in onset symptoms. However, fatigue was a common post-COVID-19 symptom regardless of the variant.
Article
Nursing
Yong Huang et al.
Summary: This study retrospectively analyzed electronic health records from the University of California and found that the prevalence of post-acute sequelae of SARS-CoV-2 (PASC) was 11%. Five symptom clusters associated with PASC were identified. Women were more likely than men to develop PASC, with this pattern observed across different age groups and ethnicities.
CLINICAL NURSING RESEARCH
(2022)
Article
Medicine, General & Internal
Sarah Wulf Hanson et al.
Summary: This study estimated the proportion and duration of Long COVID symptoms in individuals with symptomatic SARS-CoV-2 infection in 2020 and 2021. The results showed differences in the prevalence and duration of Long COVID symptoms across different age and gender groups.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
(2022)
Article
Psychiatry
Mario Gennaro Mazza et al.
Summary: Fatigue is a common symptom in post-COVID-19 syndrome. This study investigated the prevalence, trajectory over time, and risk factors of post-COVID fatigue. The findings showed that fatigue symptoms worsened over time and only depressive symptoms predicted long-term fatigue. It suggests that depression after COVID-19 is associated with persistent fatigue.
JOURNAL OF PSYCHIATRIC RESEARCH
(2022)
Article
Virology
Michele Spinicci et al.
Summary: A retrospective analysis of COVID-19 patients in Italy found that most patients still experience persistent symptoms after discharge, with the most common being shortness of breath and chronic fatigue. The study also indicated that the use of oxygen support, immunosuppressants, and female sex were associated with a higher risk of long COVID symptoms.
Article
Multidisciplinary Sciences
Claire E. Hastie et al.
Summary: Understanding long-COVID is crucial in providing health and social care support as the number of SARS-CoV-2 infections continues to rise. A study conducted in Scotland examined a population cohort of 33,281 individuals with laboratory-confirmed infections and 62,957 never-infected individuals. The study found that symptomatic infections were associated with a lower recovery rate and poorer quality of life, while asymptomatic infections did not have adverse outcomes. Vaccination was found to reduce the risk of certain symptoms. This study provides important insights into the nature and factors associated with long-COVID.
NATURE COMMUNICATIONS
(2022)
Article
Psychiatry
Siwen Wang et al.
Summary: This study utilized data from three large female cohorts and found that high levels of psychological distress before SARS-CoV-2 infection may be a risk factor for developing post-COVID-19 conditions.
Article
Immunology
Dapeng Li et al.
Summary: This study investigated the long-term health outcomes of COVID-19 survivors up to 2 years after infection. The findings showed that 36.6% of patients had at least one symptom of long COVID, 35.0% still had at least one psychological symptom, 50.7% had radiographic abnormalities, and 24.0% had abnormal pulmonary function test results. Persistent abnormalities in kidney and liver function tests were also observed in a subset of participants after discharge.
EMERGING MICROBES & INFECTIONS
(2022)
Article
Medicine, General & Internal
Roy H. Perlis et al.
Summary: This study suggests that long COVID is prevalent and associated with female gender and older age, while completion of the primary vaccination series prior to infection may reduce the risk of long COVID.
Article
Immunology
Brendan O'Kelly et al.
Summary: This study explored the safety and efficacy of Low Dose Naltrexone (LDN) in patients with Post COVID-19 Syndrome (PCS), showing that LDN is safe in PCS patients and may improve well-being and reduce symptoms.
BRAIN, BEHAVIOR, & IMMUNITY - HEALTH
(2022)
Article
Health Care Sciences & Services
Kathleen R. Case et al.
Summary: This study aimed to assess health-related quality of life (HRQoL) and social determinants of health (SDoH) among COVID-19 survivors, predominantly Latino, and compare the effects with non-Latinos. The study found that COVID-19 infection is associated with HRQoL decrements, and financial concerns and interpersonal conflict are particularly associated with worse HRQoL.
JOURNAL OF PATIENT-REPORTED OUTCOMES
(2022)
Article
Immunology
Ili Margalit et al.
Summary: The study found that long-COVID fatigue may be related to autonomic dysfunction, impaired cognition, and decreased mood, suggesting a limbic-vagal pathophysiology.
CLINICAL INFECTIOUS DISEASES
(2022)
Article
Health Care Sciences & Services
Alexis L. Beatty et al.
Summary: The COVID-19 Citizen Science study is a longitudinal cohort study aiming to generate knowledge about COVID-19. As of February 2021, over 50,000 participants have enrolled with an average completion rate of surveys in the past 4 weeks of 59%. This study demonstrates important advances in digital clinical studies and highlights the future of clinical research through continued innovation in digital methods.
JMIR RESEARCH PROTOCOLS
(2021)
Article
Multidisciplinary Sciences
Yan Xie et al.
Summary: The study analyzed data from the US Department of Veterans Affairs healthcare databases to estimate the burden of Post-Acute Sequelae of SARS-CoV-2 infection (PASC), finding approximately 73.43 PASC cases per 1000 persons at 6 months. The burden of PASC varied by demographic groups and baseline health status, with more severe acute infection leading to higher burden. The study highlights the substantial burden of PASC and the importance of considering different population groups when planning healthcare strategies.
NATURE COMMUNICATIONS
(2021)
Article
Medicine, General & Internal
Maxime Taquet et al.
Summary: This study investigated the incidence and co-occurrence of long-COVID features in COVID-19 survivors, with comparisons to influenza patients, using electronic health records data. The findings showed that long-COVID clinical features were more commonly reported after COVID-19 infection, and differences were associated with sex, age, and illness severity.
Article
Immunology
Jana L. Hirschtick et al.
Summary: The study found that post-acute sequelae of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection (PASC) is highly prevalent, especially among cases reporting severe initial symptoms. The prevalence of COVID-19 at 30 and 60 days post-onset was high even among nonhospitalized respondents and those reporting mild symptoms.
CLINICAL INFECTIOUS DISEASES
(2021)
Review
Medicine, General & Internal
Destin Groff et al.
Summary: This systematic review found that more than half of COVID-19 survivors experienced PASC 6 months after recovery, with the most common effects being functional mobility impairments, pulmonary abnormalities, and mental health disorders.
Article
Multidisciplinary Sciences
Ziyad Al-Aly et al.
Summary: This study comprehensively describes the post-acute sequelae of COVID-19 using national healthcare databases, finding increased risk of death and use of health resources beyond the first 30 days of illness, as well as incident sequelae in various organ systems, increased use of therapeutic agents, and evidence of laboratory abnormalities. The findings show a risk gradient according to the severity of acute COVID-19 infection and highlight the burden of health loss experienced by patients who survive the acute phase.
Article
Public, Environmental & Occupational Health
Kyle Yomogida et al.
MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
(2021)
Article
Medicine, General & Internal
Eric J. Lenze et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
(2020)
Article
Clinical Neurology
Kurt Kroenke et al.
JOURNAL OF AFFECTIVE DISORDERS
(2009)
Article
Public, Environmental & Occupational Health
Nancy Adler et al.
SOCIAL SCIENCE & MEDICINE
(2008)
Article
Medicine, General & Internal
Erik von Elm et al.
ANNALS OF INTERNAL MEDICINE
(2007)
Article
Medicine, General & Internal
Robert L. Spitzer et al.
ARCHIVES OF INTERNAL MEDICINE
(2006)
